Documentation of the Efficacy of Desmopressin (MINIRIN Parenteral 4 Microgram/ml Solution for Injection) Within the Context of Surgical Procedures

Trial Profile

Documentation of the Efficacy of Desmopressin (MINIRIN Parenteral 4 Microgram/ml Solution for Injection) Within the Context of Surgical Procedures

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Desmopressin (Primary)
  • Indications Platelet dysfunction
  • Focus Therapeutic Use
  • Acronyms RAPID
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 23 Jun 2016 Status changed from recruiting to completed.
    • 21 Apr 2016 Planned number of patients changed from 200 to 30.
    • 21 Apr 2016 Planned End Date changed from 1 Sep 2016 to 1 May 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top